Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer

By sjmartinez • January 14, 2023

Ganatra S, Dani SS, Yang EH, Zaha VG, Nohria A. Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer. JACC CardioOncol. 2022 Dec 20;4(5):616-623. doi: 10.1016/j.jaccao.2022.07.014. PMID: 36636447; PMCID: PMC9830211.

Tags: arrhythmia, B-cell maturation antigen, BCMA, bispecific T-cell engager, BiTE, BiTE therapy, CAR, CAR T-cell therapy, Cardiology/Epi, cardiomyopathy, cardiotoxicity, chimeric antigen receptor, CRS, cytokine release syndrome, heart failure, Hematology/Oncology, HF, ICSR, IL, individual case safety report, interleukin, left ventricular ejection fraction, LVEF, MACE, major adverse cardiovascular event(s), Publications, TIL, tumor-infiltrating lymphocyte, tumor-infiltrating lymphocytes

Ventricular Repolarization in Healthy Young Adults Who Use Combusted Cannabis: A Cross-Sectional Parallel Group Comparison Study

Hampilos K, Fong R, Sanchez J, Ruedisueli I, Lopez S, Zhao K, Gornbein J, Cooper ZD, Middlekauff H. Ventricular Repolarization in Healthy Young Adults Who[...]

The 2018 World Cancer Research Fund /American Institute for Cancer Research Score and Cancer Risk: Results from the Diabetes Prevention Program Outcomes Study

Tjaden AH, Goldbaum AA, Edelstein SL, Heckman-Stoddard BM, Reedy J, Herman WH, Hoskin M, Knowler WC, Schlögl M, Temple KA, Venditti EM, Watson K, Temprosa[...]

Mortality trends related to cardiogenic shock in heart failure patients aged 25 and older across the United States: A study utilizing the CDC WONDER database from 1999 to 2023

Muhammad AN, Neppala S, Chigurupati HD, Rehan MO, Naveed H, Iqbal R, Azeem B, Ali A, Ahmed M, Upreti P, Haider MZ, Sattar Y, Rana[...]